Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterLetter

Individuals with IgG4-related Disease Do Not Have an Increased Frequency of the K409 Variant of IgG4 that Compromises Fab-arm Exchange

MAIMUNA AHMAD, VINAY S. MAHAJAN, HAMID MATTOO, JOHN H. STONE and SHIV PILLAI
The Journal of Rheumatology January 2014, 41 (1) 185-187; DOI: https://doi.org/10.3899/jrheum.131017
MAIMUNA AHMAD
Center for Cancer Research, Massachusetts General Hospital;
Roles: Undergraduate Research Fellow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VINAY S. MAHAJAN
Center for Cancer Research, Massachusetts General Hospital;
MD, PhD
Roles: Research Fellow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HAMID MATTOO
Center for Cancer Research, Massachusetts General Hospital;
PhD
Roles: Research Fellow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOHN H. STONE
Professor of Medicine, Harvard Medical School, Director, Clinical Rheumatology, Massachusetts General Hospital;
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHIV PILLAI
Professor of Medicine and Health Sciences and Technology, Harvard Medical School, Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pillai{at}helix.mgh.harvard.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

To the Editor:

Immunoglobulin (Ig)G4 is considered a noninflammatory antibody because of its relative inability to fix complement and its poor binding to activating Fc receptors1,2. This antibody is also unique in its ability to exchange “half-antibodies” comprised of 1 heavy chain and 1 light chain by a process called “Fab-arm exchange”3. Fab-arm exchange is thought to render IgG4 functionally monovalent, interfering with its ability to crosslink target antigens and limiting its ability to form large immune complexes. Apart from the limited ability of IgG4 to bind to activating Fc receptors and its inability to fix complement, Fab-arm exchange of IgG4 may also contribute to the putative immunoregulatory properties of this isotype3. Fab-arm exchange is facilitated by residues in the hinge region, as well as in the CH3 domain of IgG4, which are unique to this subclass4. An arginine residue (R409) in the CH3 domain of IgG4, unique to the IgG4 subclass, is necessary for Fab-arm exchange4. Analysis of the crystal structure of the CH3 domain of IgG4 suggests that this arginine residue (R409) facilitates Fab-arm exchange by preventing the proper formation of an interchain hydrogen bond network that is generated in other IgG isotypes, which all have a lysine in position 4095.

A single-nucleotide polymorphism (SNP) in the CH3 exon of IgG4 results in a nonsynonymous change in codon 409 (AGG > AAG) and alters the R409 residue, which is critical for Fab-arm exchange. This SNP was previously recognized as an isoallotypic variant of IgG4, in which a lysine (K409) is present in place of arginine (R409) in the CH3 domain of IgG46. The K409 variant of IgG4 resembles IgG1, IgG2, and IgG3, which also encode a lysine at this position (Figure 1), and do not undergo Fab-arm exchange5. Serum concentrations of IgG4 correlate with certain IgG allotypes, some of which are genetically linked to the K409 variant of IgG47. It has been speculated that the K409 variant of IgG4 might be enriched in subjects with IgG4-related disease (IgG4-RD) and that this polymorphic variant could contribute to the pathogenesis of IgG4-RD, a fibroinflammatory disorder of possible autoimmune etiology, characterized by elevations in circulating IgG4 levels as well as an expansion of IgG4+ plasma cells in the affected tissues8,9. Although extensive genetic studies in IgG4-RD have not yet been reported, it remains likely that IgG4-RD is caused by environmental triggers in a genetically susceptible background.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Single-nucleotide polymorphisms (SNP) in the CH3 exon of immunoglobulin (Ig)G4. SNP (shown in boldface) in the CH3 exon of IgG4 are depicted in an alignment of the CH3 exons of IgG1, IgG2, IgG3, IgG4, and IgGP. The amino acid translation of the IgG4 CH3 exon is shown below the alignment. The positions of the primers used for specific amplification of the CH3 exon of IgG4 are indicated by arrows. The minor allele of rs77498506 is identical to the K409 variant of IgG4 and results in a nonsynonymous substitution from arginine to lysine (AGG > AAG). The codon encoding arginine (R409) is underlined.

We have evaluated the occurrence of the K409 variant of IgG4 in a cohort of 25 subjects with IgG4-RD who presented to the rheumatology clinic at the Massachusetts General Hospital. All patients signed written informed consent for the investigations described. All had biopsy-proven IgG4-RD affecting 1 or more of the following organs: pancreas, lacrimal gland, submandibular gland, parotid gland, biliary tree, retroperitoneum, kidney (tubulointerstitial nephritis), lymph node, lung, mediastinum, aorta, common carotid artery, palate, pharynx, larynx, lymph node, and skin. Nineteen patients self-identified as white, 3 as Asian, and 2 as black. One patient declined to provide information about race.

Because of the high degree of nucleotide sequence conservation among the constant regions encoding IgG subclasses and the IgGP pseudogene, the K409 variant of IgG4 is not included in most high-throughput genotyping panels (Figure 1). Therefore, we designed primers for the specific amplification of the CH3 exon of IgG4 (5’-CAA CAA AGG CCT CCC GTC CT-3’ and 5’-GGG GCT TGC CGG CCC TG-3’). PCR was performed for 35 cycles at 67°C (KAPA2G HotStart ReadyMix; KapaBiosystems) using 50–100 ng of genomic DNA as a template. The PCR products were sequenced using the Sanger method. The resulting sequences included several bases that were specific to IgG4, which were used to confirm that the amplified sequences were indeed IgG4. The amplified region includes 5 SNP: rs56133431, rs8010914, rs77498506, rs17841088, and rs201617483 (Figure 1). The K409 variant of IgG4 corresponds to the minor allele (T) of the rs77498506 SNP. The rest of the SNP encode synonymous substitutions.

The SNP frequencies in the CH3 exon of IgG4 observed in the subjects with IgG4-RD are summarized in Table 1. The SNP frequencies in control populations from the dbSNP database are also listed for comparison. We did not identify any subject with the K409 variant of IgG4 in our study cohort. These data suggest that this variant is not a major contributor to disease susceptibility in IgG4-RD. Statistical analyses have limitations when the frequency of an allele is zero in a population, and it is reasonable to assume that the frequency of the K409 polymorphism is in the same range as the control population of healthy subjects of European descent. Based on the modified Wald method of CI determination and assuming random sampling of IgG4-RD subjects, we estimate with > 95% CI that the K409 variant of IgG4, which compromises Fab-arm exchange, is absent in at least 88.4% of subjects with IgG4-RD. Although IgG4 Fab-arm exchange has not been directly examined in individuals with disease at the protein level, we believe that dysregulation of IgG4 Fab-arm exchange is unlikely to be a major contributor to the pathogenesis of this disease. Rather, the pathology in IgG4-RD appears to be driven by T cells10. However, immunological evaluation of individuals bearing the K409 variant of IgG4 may help in a broader understanding of the pathophysiological implications of IgG4 Fab-arm exchange.

View this table:
  • View inline
  • View popup
Table 1.

Frequency of single-nucleotide polymorphisms (SNP) in the CH3 exon of IgG4.

Footnotes

  • Supported by grants AI 076505 and AI064930 to SP from the US National Institutes of Health.

REFERENCES

  1. 1.↵
    1. Bindon CI,
    2. Hale G,
    3. Bruggemann M,
    4. Waldmann H
    . Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q. J Exp Med 1988;168:127–42.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Bruhns P,
    2. Iannascoli B,
    3. England P,
    4. Mancardi DA,
    5. Fernandez N,
    6. Jorieux S,
    7. et al.
    Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 2009;113:3716–25.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Aalberse RC,
    2. Stapel SO,
    3. Schuurman J,
    4. Rispens T
    . Immunoglobulin G4: an odd antibody. Clin Exp Allergy 2009;39:469–77.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Labrijn AF,
    2. Rispens T,
    3. Meesters J,
    4. Rose RJ,
    5. den Bleker TH,
    6. Loverix S,
    7. et al.
    Species-specific determinants in the IgG CH3 domain enable Fab-arm exchange by affecting the noncovalent CH3-CH3 interaction strength. J Immunol 2011;187:3238–46.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Davies AM,
    2. Rispens T,
    3. den Bleker TH,
    4. McDonnell JM,
    5. Gould HJ,
    6. Aalberse RC,
    7. et al.
    Crystal structure of the human IgG4 C(H)3 dimer reveals the role of Arg409 in the mechanism of Fab-arm exchange. Mol Immunol 2013;54:1–7.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Brusco A,
    2. Saviozzi S,
    3. Cinque F,
    4. DeMarchi M,
    5. Boccazzi C,
    6. de Lange G,
    7. et al.
    Molecular characterization of immunoglobulin G4 gene isoallotypes. Eur J Immunogenet 1998;25:349–55.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Steinberg AG,
    2. Morell A,
    3. Skvaril F,
    4. van Loghem E
    . The effect of Gm(23) on the concentration of IgG2 and IgG4 in normal human serum. J Immunol 1973;110:1642–5.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Pandey JP
    . Genetic markers of immunoglobulin G as potential risk factors for IgG4-related disease. J Rheumatol 2012;39:2048.
    OpenUrlFREE Full Text
  9. 9.↵
    1. Stone JH,
    2. Zen Y,
    3. Deshpande V
    . IgG4-related disease. N Engl J Med 2012;366:539–51.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Mahajan VS,
    2. Mattoo H,
    3. Deshpande V,
    4. Pillai S,
    5. Stone JH
    . IgG4-Related Disease. Annu Rev Pathol 2013 Oct 2 (E-pub ahead of print).
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 41, Issue 1
1 Jan 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Individuals with IgG4-related Disease Do Not Have an Increased Frequency of the K409 Variant of IgG4 that Compromises Fab-arm Exchange
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Individuals with IgG4-related Disease Do Not Have an Increased Frequency of the K409 Variant of IgG4 that Compromises Fab-arm Exchange
MAIMUNA AHMAD, VINAY S. MAHAJAN, HAMID MATTOO, JOHN H. STONE, SHIV PILLAI
The Journal of Rheumatology Jan 2014, 41 (1) 185-187; DOI: 10.3899/jrheum.131017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Individuals with IgG4-related Disease Do Not Have an Increased Frequency of the K409 Variant of IgG4 that Compromises Fab-arm Exchange
MAIMUNA AHMAD, VINAY S. MAHAJAN, HAMID MATTOO, JOHN H. STONE, SHIV PILLAI
The Journal of Rheumatology Jan 2014, 41 (1) 185-187; DOI: 10.3899/jrheum.131017
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Smoking Cessation and Gout Risk in Indigenous Populations: A Call for Causal Inference and Multiethnic Mendelian Randomization
  • Promising Imaging Methods for Assessment of Structural Progression in Axial Spondyloarthritis
  • Tumor Necrosis Factor Inhibitor Therapy in Polyarteritis Nodosa: Expanding Evidence From Systemic to Cutaneous Disease
Show more Letter

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire